Please use this identifier to cite or link to this item:
https://dipositint.ub.edu/dspace/handle/2445/181487
Title: | Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies |
Author: | Moreno García, Estela Puerta Alcalde, Pedro Gariup, Giuseppe Fernández Ruiz, Mario López Cortés, Luis Eduardo Cuervo Requena, Guillermo Salavert, Miguel Merino, Paloma Machado, Marina Guinea, Jesús García Rodríguez, Julio Garnacho Montero, José Cardozo Espinola, Celia Peman,Javier Montejo, Marta Fortún, Jesús Almirante, Benito Castro, Carmen Rodríguez Baño, Jesús Aguado, José María Martínez, J. Alfredo, 1957- Carratalà, Jordi Soriano Viladomiu, Alex Garcia Vidal, Carolina |
Keywords: | Candidiasi Terapèutica Candidiasis Therapeutics |
Issue Date: | 16-May-2021 |
Publisher: | Oxford University Press (OUP) |
Abstract: | Background. There are no clear criteria for antifungal de-escalation after initial empirical treatments. We hypothesized that early de-escalation (ED) (within 5 days) to fluconazole is safe in fluconazole-susceptible candidemia with controlled source of infection. Methods. This is a multicenter post hoc study that included consecutive patients from 3 prospective candidemia cohorts (20072016). The impact of ED and factors associated with mortality were assessed. Results. Of 1023 candidemia episodes, 235 met inclusion criteria. Of these, 54 (23%) were classified as the ED group and 181 (77%) were classified as the non-ED group. ED was more common in catheter-related candidemia (51.9% vs 31.5%; P = .006) and episodes caused by Candida parapsilosis, yet it was less frequent in patients in the intensive care unit (24.1% vs 39.2%; P = .043), infections caused by Nakaseomyces glabrata (0% vs 9.9%; P = .016), and candidemia from an unknown source (24.1% vs 47%; P = .003). In the ED and non-ED groups, 30-day mortality was 11.1% and 29.8% (P = .006), respectively. Chronic obstructive pulmonary disease (odds ratio [OR], 3.97; 95% confidence interval [CI], 1.48-10.61), Pitt score > 2 (OR, 4.39; 95% CI, 1.94-9.20), unknown source of candidemia (OR, 2.59; 95% CI, 1.14-5.86), candidemia caused by Candida albicans (OR, 3.92; 95% CI, 1.48-10.61), and prior surgery (OR, 0.29; 95% CI, 0.08-0.97) were independent predictors of mortality. Similar results were found when a propensity score for receiving ED was incorporated into the model. ED had no significant impact on mortality (OR, 0.50; 95% CI, 0.16-1.53). Conclusions. Early de-escalation is a safe strategy in patients with candidemia caused by fluconazole-susceptible strains with controlled source of bloodstream infection and hemodynamic stability. These results are important to apply antifungal stewardship strategies. |
Note: | Reproducció del document publicat a: https://doi.org/10.1093/ofid/ofab250 |
It is part of: | Open Forum Infectious Diseases, 2021, vol. 8, num. 6 |
URI: | http://hdl.handle.net/2445/181487 |
Related resource: | https://doi.org/10.1093/ofid/ofab250 https://doi.org/10.1093/ofid/ofac180 |
ISSN: | 2328-8957 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ofab250.pdf | 349.26 kB | Adobe PDF | View/Open | |
Correction_Early_Stepdown.pdf | Correction | 112.58 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License